TITLE:
      Naltrexone Maintenance Treatment of Alcoholism
SUMMARY:
      The purpose of this study is to determine the long-term effectiveness of naltrexone
      treatment in alcohol-dependent patients who respond to short-term treatment. Those who
      respond to short-term treatment will be randomized to a 1-year, double-blind,
      placebo-controlled maintenance phase with a 6-month posttreatment followup.
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

          -  Meets criteria for alcohol dependence.

          -  Expresses a desire to cut down or stop drinking.

        Exclusion Criteria:

          -  Currently meets criteria for dependence on substances other than alcohol.

          -  History of opiate dependence or evidence of current opiate use.

          -  Significant medical disorders that will increase potential risk or interfere with
             study participation.

          -  Liver function tests more than 3 times normal or elevated bilirubin.

          -  Female patients who are pregnant, nursing, or not using a reliable method of birth
             control.

          -  Inability to understand and provide a consent form.

          -  Treatment with an investigational drug during the previous month.

          -  Prior treatment with naltrexone.

          -  Chronic treatment with any narcotic-containing medications during the previous month.

          -  Sensitivity to naltrexone as evidenced by adverse drug experiences especially with
             narcotic containing analgesics or opioid antagonists.

          -  Current treatment with disulfiram.

          -  More than 6 weeks of abstinence.

          -  Meets criteria for a major psychiatric disorder and is in need of, or currently
             undergoing pharmacotherapy.
